SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-22-004246
Filing Date
2022-02-28
Accepted
2022-02-28 16:20:36
Documents
91
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mrtx-20211231.htm   iXBRL 10-K 2024414
2 EX-10.13 mrtx-20211231xex1013.htm EX-10.13 26991
3 EX-10.29 mrtx-20211231xex1029.htm EX-10.29 77514
4 EX-10.30 mrtx-20211231xex1030.htm EX-10.30 72556
5 EX-21.1 mrtx12312021-exhibit211.htm EX-21.1 3098
6 EX-23.1 mrtx12312021-exhibit231.htm EX-23.1 5052
7 EX-31.1 mrtx-20211231xex311.htm EX-31.1 14088
8 EX-31.2 mrtx-20211231xex312.htm EX-31.2 15011
9 EX-32.1 mrtx-20211231xex321.htm EX-32.1 7821
15 mrtx-20211231_g1.jpg GRAPHIC 33704
  Complete submission text file 0001628280-22-004246.txt   9136768

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20211231.xsd EX-101.SCH 63171
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrtx-20211231_cal.xml EX-101.CAL 69317
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20211231_def.xml EX-101.DEF 233309
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20211231_lab.xml EX-101.LAB 721778
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20211231_pre.xml EX-101.PRE 443176
85 EXTRACTED XBRL INSTANCE DOCUMENT mrtx-20211231_htm.xml XML 1646423
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35921 | Film No.: 22689919
SIC: 2834 Pharmaceutical Preparations